Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
930studies shown
Showing 589-600 of 930
Drug study icon
CompletedNCT03367533

Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response, study

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

Remote / online
Why is this study shown?

This study includes Bipolarity among several conditions.

PTSD, Depression, ...DrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
PTSD, Depression, ...
Other study type icon
CompletedNCT02323763

An fMRI Study on Temporal Discounting in Bipolarity

This study exists to compare options and see whether brain scans or other body measurements offers something meaningfully different. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, Suicidality, ...OtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Bipolarity, Suicidality, ...
Device study icon
CompletedNCT02640950

An Open Label study of TMS Therapy for Depression in bipolarity

This study exists to understand whether the medication TMS is both safe enough and useful enough to take further. Researchers are trying to understand whether the medication TMS can give earlier or clearer feedback during care.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDeviceA study involving a tool, app, wearable, test, or medical device.Over 18 Years
Countries
United States
Sponsor
Sheppard Pratt Health System
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00288366

Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Northwestern University
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT00585273

Antipsychotics and Blood Vessel Function

This study exists to understand how smoking support or smoking-related treatment holds up over time after the earliest research stage. Researchers are trying to understand whether smoking support or smoking-related treatment can better support energy, concentration, and everyday functioning.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, BipolarityOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
Jess G. Fiedorowicz
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT02918370

Aripiprazole for Bipolarity and Addiction

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand whether a medication treatment can work better when mental health difficulties overlap with substance use.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, AddictionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Bipolarity, Addiction
Drug study icon
CompletedNCT00226317

Aripiprazole in the Treatment of Depression in bipolarity

This study exists to see whether this type of care is workable and worth testing more broadly. Researchers are trying to understand whether this type of care can give earlier or clearer feedback during care.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
Cambridge Health Alliance
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00102518

Aripiprazole Safety and Tolerability Study

This study is completed in the United States. It focuses on Schizophrenia.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, BipolarityDrugFrom 10 Years to 17 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT00198198

Aripiprazole Treatment of Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Indiana University
Condition
Bipolarity, Depression
Drug study icon
TerminatedNCT01807741

Asenapine for Depression in bipolarity

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

In United States
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
University of Cincinnati
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.